Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Illumina, Inc.(ILMN) | 119,196 | 119,196 | 0 | $16.60M | $16.37M | 15.17% | -$228.9K |
| Harmony Biosciences Holdings, Inc.(HRMY) | 368,665 | 368,665 | 0 | $11.91M | $12.38M | 11.47% | +$471.9K |
| Alpine Immune Sciences Inc | 263,940 | 263,940 | 0 | $5.03M | $10.46M | 9.69% | +$5.43M |
| Oculis Holding AG(OCS) | 518,933 | 436,378 | -82,555 | $5.83M | $5.26M | 4.87% | -$569.3K |
| Standard BioTools Inc.(LAB) | 0 | 1,883,179 | +1,883,179 | $0 | $5.10M | 4.73% | +$5.10M |
| Exscientia PlcADS | 859,892 | 859,892 | 0 | $5.51M | $4.92M | 4.56% | -$593.3K |
| Xenon Pharmaceuticals Inc.(XENE) | 106,680 | 106,680 | 0 | $4.91M | $4.59M | 4.26% | -$321.1K |
| Geron Corporation(GERN) | 913,550 | 1,324,550 | +411,000 | $1.93M | $4.37M | 4.05% | +$2.44M |
| Incyte Corporation(INCY) | 32,022 | 74,022 | +42,000 | $2.01M | $4.22M | 3.91% | +$2.21M |
| Merus N V | 137,038 | 89,516 | -47,522 | $3.77M | $4.03M | 3.73% | +$262.4K |
| BeOne Medicines AGADR(ONC) | 12,022 | 23,022 | +11,000 | $2.17M | $3.60M | 3.34% | +$1.43M |
| Kalvista Pharmaceuticals Inc | 304,277 | 219,277 | -85,000 | $3.73M | $2.60M | 2.41% | -$1.13M |
| Longboard Pharmaceuticals In | 0 | 118,255 | +118,255 | $0 | $2.55M | 2.37% | +$2.55M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 96,100 | 96,100 | 0 | $2.84M | $2.41M | 2.24% | -$422.8K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 40,070 | 49,120 | +9,050 | $1.84M | $2.13M | 1.97% | +$286.4K |
| Ascendis Pharma A/SADR(ASND) | 0 | 13,600 | +13,600 | $0 | $2.06M | 1.90% | +$2.06M |
| Acadia Pharmaceuticals Inc | 29,984 | 102,984 | +73,000 | $938.8K | $1.90M | 1.76% | +$965.4K |
| Replimune Group, Inc.(REPL) | 184,739 | 204,939 | +20,200 | $1.56M | $1.67M | 1.55% | +$117.0K |
| Bolt Biotherapeutics Inc | 1,166,952 | 1,166,952 | 0 | $1.31M | $1.63M | 1.51% | +$326.7K |
| Rani Therapeutics Holdings, Inc.CL A(RANI) | 493,584 | 493,584 | 0 | $1.64M | $1.54M | 1.42% | -$103.7K |
| Exelixis, Inc.(EXEL) | 64,200 | 64,200 | 0 | $1.54M | $1.52M | 1.41% | -$16.7K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,182 | 5,682 | +4,500 | $273.5K | $1.52M | 1.41% | +$1.24M |
| Aerovate Therapeutics Inc | 47,936 | 47,936 | 0 | $1.08M | $1.42M | 1.31% | +$332.7K |
| Pacific Biosciences of California, Inc.(PACB) | 274,488 | 274,488 | 0 | $2.69M | $1.03M | 0.95% | -$1.66M |
| BioMarin Pharmaceutical Inc.(BMRN) | 3,615 | 10,815 | +7,200 | $348.6K | $944.6K | 0.88% | +$596.0K |
| Neumora Therapeutics, Inc.(NMRA) | 0 | 63,315 | +63,315 | $0 | $870.6K | 0.81% | +$870.6K |
| Cabaletta Bio, Inc.(CABA) | 47,150 | 47,150 | 0 | $1.07M | $804.4K | 0.75% | -$265.9K |
| Entrada Therapeutics, Inc.(TRDA) | 49,082 | 49,082 | 0 | $740.6K | $695.5K | 0.64% | -$45.2K |
| Biomea Fusion, Inc.(BMEA) | 40,000 | 40,000 | 0 | $580.8K | $598.0K | 0.55% | +$17.2K |
| Athira Pharma Inc | 180,000 | 180,000 | 0 | $437.4K | $493.2K | 0.46% | +$55.8K |
| Tourmaline Bio Inc | 0 | 20,987 | +20,987 | $0 | $480.6K | 0.45% | +$480.6K |
| ALX Oncology Holdings Inc.(ALXO) | 41,950 | 41,950 | 0 | $624.6K | $467.7K | 0.43% | -$156.9K |
| Immunocore Holdings plcADS(IMCR) | 0 | 6,750 | +6,750 | $0 | $438.8K | 0.41% | +$438.8K |
| Kymera Therapeutics, Inc.(KYMR) | 0 | 10,875 | +10,875 | $0 | $437.2K | 0.41% | +$437.2K |
| Springworks Therapeutics Inc | 0 | 7,450 | +7,450 | $0 | $366.7K | 0.34% | +$366.7K |
| Roivant Sciences Ltd.SHS(ROIV) | 0 | 32,470 | +32,470 | $0 | $342.2K | 0.32% | +$342.2K |
| Dbv Technologies S AADR | 370,950 | 370,950 | 0 | $353.4K | $277.9K | 0.26% | -$75.6K |
| Revolution Medicines, Inc.(RVMD) | 0 | 7,300 | +7,300 | $0 | $235.3K | 0.22% | +$235.3K |
| AbCellera Biologics Inc.(ABCL) | 12,521 | 50,971 | +38,450 | $71.5K | $230.9K | 0.21% | +$159.4K |
| Affimed N V | 0 | 37,247 | +37,247 | $0 | $197.4K | 0.18% | +$197.4K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 17,847 | 36,847 | +19,000 | $106.9K | $187.2K | 0.17% | +$80.3K |
| Kodiak Sciences Inc.(KOD) | 19,622 | 31,922 | +12,300 | $59.7K | $167.9K | 0.16% | +$108.3K |
| Immatics N.V.SHS(IMTX) | 0 | 15,700 | +15,700 | $0 | $165.0K | 0.15% | +$165.0K |
| Fibrogen Inc | 62,106 | 62,106 | 0 | $55.0K | $145.9K | 0.14% | +$90.9K |
| Galera Therapeutics Inc | 613,223 | 613,223 | 0 | $89.2K | $85.9K | 0.08% | -$3.3K |
| Affimed N V | 372,472 | 0 | -372,472 | $232.8K | $0 | — | -$232.8K |
| argenx SEADR(ARGX) | 1,430 | 0 | -1,430 | $544.0K | $0 | — | -$544.0K |
| Cerus Corporation(CERS) | 14,172 | 0 | -14,172 | $30.6K | $0 | — | -$30.6K |
| Eargo Inc | 147,904 | 0 | -147,904 | $383.1K | $0 | — | -$383.1K |
| Karuna Therapeutics Inc | 225,688 | 0 | -225,688 | $71.43M | $0 | — | -$71.43M |
| Somalogic IncCL A | 1,696,558 | 0 | -1,696,558 | $4.29M | $0 | — | -$4.29M |